India to Overhaul Pharmacy Regulation with New National Commission Bill

The Indian government is moving to repeal the seven-decade-old Pharmacy Act of 1948, replacing it with the National Pharmacy Commission Bill, 2026. This legislative shift aims to modernize the regulatory framework governing pharmacy education and practice across the country. The proposed bill will establish a central National Pharmacy Commission, tasked with overseeing the sector and ensuring consistent standards. Underneath the central commission, the new structure will feature four specialized boards. These boards are expected to manage specific aspects of pharmacy, potentially including education, registration, ethics, and professional development. A key economic implication of this reform is the introduction of a mandatory exit examination for all pharmacy graduates. This examination will be a prerequisite for obtaining a license to practice, a significant change from the current system. The stated goal of this overhaul is to enhance the quality of pharmacy professionals and ensure better public health outcomes. By centralizing regulatory authority and implementing standardized evaluations, the government intends to streamline the licensing process and potentially reduce variations in professional competence across different regions and institutions. For the healthcare sector, this could mean a more uniformly skilled workforce, potentially impacting drug dispensing, patient counseling, and the overall pharmaceutical supply chain. The transition from the 1948 Act to the 2026 Bill underscores a governmental effort to adapt an antiquated regulatory system to the demands of a rapidly evolving healthcare landscape and pharmaceutical industry.